INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 368 filers reported holding INTRA CELLULAR THERAPIES INC in Q2 2024. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $43,386 | +32.6% | 633,458 | +34.0% | 0.14% | +34.3% |
Q1 2024 | $32,710 | -40.9% | 472,687 | -38.8% | 0.11% | -45.7% |
Q4 2023 | $55,360 | +63.0% | 772,967 | +18.5% | 0.20% | +56.7% |
Q3 2023 | $33,964 | -58.5% | 652,030 | -49.6% | 0.13% | -55.0% |
Q2 2023 | $81,858 | +114.7% | 1,292,768 | +83.6% | 0.28% | +104.3% |
Q1 2023 | $38,118 | -18.8% | 703,931 | -20.7% | 0.14% | -17.9% |
Q4 2022 | $46,959 | -100.0% | 887,373 | -56.0% | 0.17% | -51.0% |
Q3 2022 | $93,929,000 | -11.1% | 2,018,686 | +9.1% | 0.34% | -8.3% |
Q2 2022 | $105,652,000 | -12.9% | 1,850,949 | -6.6% | 0.37% | +15.8% |
Q1 2022 | $121,239,000 | +8.7% | 1,981,356 | -7.0% | 0.32% | +27.2% |
Q4 2021 | $111,527,000 | +43.3% | 2,130,820 | +2.0% | 0.25% | +36.6% |
Q3 2021 | $77,842,000 | -11.1% | 2,088,034 | -2.7% | 0.19% | -11.8% |
Q2 2021 | $87,583,000 | +21.6% | 2,145,588 | +1.1% | 0.21% | +15.3% |
Q1 2021 | $72,004,000 | +2761.8% | 2,122,140 | +3174.1% | 0.18% | +2187.5% |
Q2 2016 | $2,516,000 | -40.2% | 64,816 | -57.2% | 0.01% | -38.5% |
Q1 2016 | $4,206,000 | -58.0% | 151,264 | -18.7% | 0.01% | -56.7% |
Q4 2015 | $10,007,000 | +83.6% | 186,033 | +36.7% | 0.03% | +87.5% |
Q3 2015 | $5,450,000 | – | 136,119 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 360,000 | $11,502,000 | 2.65% |
Redmile Group, LLC | 610,171 | $19,495,000 | 1.60% |
Pier Capital, LLC | 257,256 | $8,219,000 | 1.18% |
WALL STREET ASSOCIATES | 358,857 | $11,465,000 | 1.08% |
SENZAR ASSET MANAGEMENT, LLC | 161,300 | $5,154,000 | 0.88% |
Rhenman & Partners Asset Management AB | 206,000 | $6,582,000 | 0.79% |
EAM Investors, LLC | 152,389 | $4,869,000 | 0.57% |
EDMOND DE ROTHSCHILD (SUISSE) S.A. | 50,000 | $1,598,000 | 0.51% |
Visium Asset Management, LP | 1,051,479 | $33,595,000 | 0.48% |
SPHERA FUNDS MANAGEMENT LTD. | 128,000 | $4,090,000 | 0.40% |